Trials
Search / Trial NCT05642988

Application of Wearable Technology in High-risk Surgical Patients in the Perioperative Period

Launched by MATER MISERICORDIAE UNIVERSITY HOSPITAL · Nov 30, 2022

Trial Information

Current as of January 22, 2025

Completed

Keywords

ClinConnect Summary

Patients undergoing major abdominal and pelvic surgery can have re-admission rates of over 20% in the first 90-days after surgery.

In Ireland the 30-day mortality following emergency abdominal surgery is 6.6%, and 90-day mortality 11.6% (1). Furthermore, 20% of post-operative deaths occur after hospital discharge in those over 80 years of age, of which over 95% occurs during the first six-weeks (2).

Despite this high risk, many patients are discharged home from hospital when medically fit and continuous monitoring discontinues. In hospital, patient monitoring is routine to identify patien...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Over 18 years of age
  • Scheduled to undergo or recently undergone major intra-cavity abdominal surgery
  • Able to give informed written consent to participate
  • Exclusion Criteria:
  • Deemed unfit for surgery
  • Unable or unwilling to comply with remote monitoring for any reason
  • Unable or unwilling to fill in a questionnaire in English

About Mater Misericordiae University Hospital

Mater Misericordiae University Hospital is a leading academic healthcare institution dedicated to advancing patient care through innovative research and clinical trials. Located in Dublin, Ireland, the hospital is renowned for its commitment to improving health outcomes by integrating cutting-edge medical research with clinical practice. As a sponsor of clinical trials, Mater Misericordiae University Hospital collaborates with multidisciplinary teams to facilitate the development of new therapies and interventions, ensuring rigorous adherence to ethical standards and regulatory guidelines. The hospital's focus on patient-centered research underscores its mission to enhance the quality of life for individuals and communities through evidence-based medicine.

Locations

Dublin 7, , Ireland

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials